OU Health patients part of global trial for newly approved pancreatic cancer drug - News On 6
OU Health patients part of global trial for newly approved pancreatic cancer drug News On 6
1140 материалов по теме, собраны автоматически из проверенных источников
OU Health patients part of global trial for newly approved pancreatic cancer drug News On 6
Cancer Research UK Discovery Programme Foundation Award 2026 Oncodaily
Cancer Research UK Discovery Programme Foundation Award 2026 Oncodaily
Cancer Research UK Discovery Programme Award 2026 Oncodaily
Cancer Research UK Discovery Programme Award 2026 Oncodaily
It has been nearly three years since the U.S. Food and Drug Administration (FDA) cleared the HistoSonics Edison histotripsy system to treat primary and metastatic liver tumors. To examine how the technology's adoption and use have progressed, a research team at the University of Virginia, led by Allan Tsung, M.D…
New research questions decades-old assumptions about brain cancer treatment News-Medical
New research questions decades-old assumptions about brain cancer treatment News-Medical
Results from an early-stage clinical trial, published in Nature Communications, showed encouraging outcomes among patients with newly diagnosed cancer whose tumors had spread to distant organs. Most strikingly, one patient experienced a pathologic complete response—meaning no viable cancer cells could be found—and…
Virginia Cancer Specialists Welcomes Kai-Li Liang, MD, Expanding Access to Innovative Cancer Research Across the Mid-Atlantic Morningstar
Virginia Cancer Specialists Welcomes Kai-Li Liang, MD, Expanding Access to Innovative Cancer Research Across the Mid-Atlantic Morningstar
For decades, a diagnosis of metastatic pancreatic cancer left patients and physicians facing the same harsh reality: limited options, difficult treatments and too little time. Now, a pill tested in a global clinical trial may begin to change that.
Tumor lysis syndrome (TLS) is a life-threatening emergency that occurs when large numbers of cancer cells break down rapidly, releasing substances such as uric acid into the bloodstream that can damage the kidneys and cause serious complications.
Scientists are making progress in developing new cancer treatments, but a patient's experience with cancer is shaped by more than medicine. A new sociological study finds that conflicting medical, work and family timelines compound inequality, draining resources and displacing goals for even the most advantaged…
Precancerous blood cells can actively reshape their surroundings, prematurely aging cells in the bone marrow to create conditions that favor their own growth and potentially increase the risk of blood cancer, according to a new study by researchers at The Jackson Laboratory (JAX).